Stem Cell Exosome Therapeutic - Global and China Top Players Market Share and Ranking 2023
Report Code: KNJ1665321 No. of Pages: 150 Category: Services
Publisher: Date of Publish:
Publisher: Date of Publish:
According to YH Research, the global market for Stem Cell Exosome Therapeutic should grow from US$ 153 million in 2022 to US$ 410.5 million by 2029, with a CAGR of 15.6% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Stem Cell Exosome Therapeutic market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Stem Cell Exosome Therapeutic market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Precision Medicine grew percent to account for percent of the total market sales, and Regenerative Medicine grew percent.
Exosome therapy involves using exosomes, small vesicles that are naturally produced by stem cells, to deliver therapeutic molecules to specific cells in the body.
This report studies and analyses global Stem Cell Exosome Therapeutic status and future trends, to help determine the Stem Cell Exosome Therapeutic market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Stem Cell Exosome Therapeutic, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Stem Cell Exosome Therapeutic market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Stem Cell Exosome Therapeutic by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Stem Cell Exosome Therapeutic by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Stem Cell Exosome Therapeutic key consuming regions, consumption value and demand structure
(5) Stem Cell Exosome Therapeutic industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Aegle Therapeutics
Brexogen
Cell Care Therapeutics
CHA Biotech
ExoCoBio
Exopharm
OmniSpiant
BrainStorm Cell Therapeutics
Novadip Biosciences
Unicyte AG
Exogenus Therapeutics
Creative Medical Tech
Anjarium Biosciences
Capricor Therapeutics
Kimera Labs ReNeuron
Stem Cell Medicine
Codiak Biosciencesare
Market segment by Type, covers
Mesenchymal Stem Cell (MSC)
Dendritic Cells
Umbilical MSC
Others
Market segment by Application, can be divided into
Precision Medicine
Regenerative Medicine
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Stem Cell Exosome Therapeutic product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Stem Cell Exosome Therapeutic market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Stem Cell Exosome Therapeutic market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Stem Cell Exosome Therapeutic industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Stem Cell Exosome Therapeutic Definition
1.2 Global Stem Cell Exosome Therapeutic Market Size and Forecast
1.3 China Stem Cell Exosome Therapeutic Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Stem Cell Exosome Therapeutic Market Size: China VS Global Growth Rate, 2018-2029
1.6 Stem Cell Exosome Therapeutic Market Dynamics
1.6.1 Stem Cell Exosome Therapeutic Market Drivers
1.6.2 Stem Cell Exosome Therapeutic Market Restraints
1.6.3 Stem Cell Exosome Therapeutic Industry Trends
1.6.4 Stem Cell Exosome Therapeutic Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Stem Cell Exosome Therapeutic, Global Market Share by Company, 2018-2023
2.2 Global Stem Cell Exosome Therapeutic Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Stem Cell Exosome Therapeutic Concentration Ratio
2.4 Global Stem Cell Exosome Therapeutic Mergers & Acquisitions, Expansion Plans
2.5 Global Stem Cell Exosome Therapeutic Major Companies Product Type
2.6 Head Office and Stem Cell Exosome Therapeutic Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Stem Cell Exosome Therapeutic, China Market Share by Company, 2018-2023
3.2 China Stem Cell Exosome Therapeutic Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Stem Cell Exosome Therapeutic Industry Chain
4.2 Stem Cell Exosome Therapeutic Upstream Analysis
4.2.1 Stem Cell Exosome Therapeutic Core Raw Materials
4.2.2 Main Manufacturers of Stem Cell Exosome Therapeutic Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Stem Cell Exosome Therapeutic Production Mode
4.6 Stem Cell Exosome Therapeutic Procurement Model
4.7 Stem Cell Exosome Therapeutic Industry Sales Model and Sales Channels
4.7.1 Stem Cell Exosome Therapeutic Sales Model
4.7.2 Stem Cell Exosome Therapeutic Typical Distributors
5 Sights by Type
5.1 Stem Cell Exosome Therapeutic Classification
5.1.1 Mesenchymal Stem Cell (MSC)
5.1.2 Dendritic Cells
5.1.3 Umbilical MSC
5.1.4 Others
5.2 By Type, Global Stem Cell Exosome Therapeutic Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Stem Cell Exosome Therapeutic Consumption Value, 2018-2029
6 Sights by Application
6.1 Stem Cell Exosome Therapeutic Segment by Application
6.1.1 Precision Medicine
6.1.2 Regenerative Medicine
6.1.3 Others
6.2 By Application, Global Stem Cell Exosome Therapeutic Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Stem Cell Exosome Therapeutic Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Stem Cell Exosome Therapeutic Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Stem Cell Exosome Therapeutic Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Stem Cell Exosome Therapeutic & Forecasts, 2018-2029
7.3.2 By Country, North America Stem Cell Exosome Therapeutic Market Size Market Share
7.4 Europe
7.4.1 Europe Stem Cell Exosome Therapeutic Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Stem Cell Exosome Therapeutic Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Stem Cell Exosome Therapeutic Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Stem Cell Exosome Therapeutic Market Size Market Share
7.6 South America
7.6.1 South America Stem Cell Exosome Therapeutic Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Stem Cell Exosome Therapeutic Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Stem Cell Exosome Therapeutic Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Stem Cell Exosome Therapeutic Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.3.2 By Type, U.S. Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.4.2 By Type, Europe Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.5.2 By Type, China Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.6.2 By Type, Japan Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.7.2 By Type, South Korea Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.9.2 By Type, India Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Stem Cell Exosome Therapeutic Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Aegle Therapeutics
9.1.1 Aegle Therapeutics Company Information, Head Office, Market Area and Industry Position
9.1.2 Aegle Therapeutics Company Profile and Main Business
9.1.3 Aegle Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.1.4 Aegle Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.1.5 Aegle Therapeutics Recent Developments
9.2 Brexogen
9.2.1 Brexogen Company Information, Head Office, Market Area and Industry Position
9.2.2 Brexogen Company Profile and Main Business
9.2.3 Brexogen Stem Cell Exosome Therapeutic Models, Specifications and Application
9.2.4 Brexogen Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.2.5 Brexogen Recent Developments
9.3 Cell Care Therapeutics
9.3.1 Cell Care Therapeutics Company Information, Head Office, Market Area and Industry Position
9.3.2 Cell Care Therapeutics Company Profile and Main Business
9.3.3 Cell Care Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.3.4 Cell Care Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.3.5 Cell Care Therapeutics Recent Developments
9.4 CHA Biotech
9.4.1 CHA Biotech Company Information, Head Office, Market Area and Industry Position
9.4.2 CHA Biotech Company Profile and Main Business
9.4.3 CHA Biotech Stem Cell Exosome Therapeutic Models, Specifications and Application
9.4.4 CHA Biotech Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.4.5 CHA Biotech Recent Developments
9.5 ExoCoBio
9.5.1 ExoCoBio Company Information, Head Office, Market Area and Industry Position
9.5.2 ExoCoBio Company Profile and Main Business
9.5.3 ExoCoBio Stem Cell Exosome Therapeutic Models, Specifications and Application
9.5.4 ExoCoBio Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.5.5 ExoCoBio Recent Developments
9.6 Exopharm
9.6.1 Exopharm Company Information, Head Office, Market Area and Industry Position
9.6.2 Exopharm Company Profile and Main Business
9.6.3 Exopharm Stem Cell Exosome Therapeutic Models, Specifications and Application
9.6.4 Exopharm Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.6.5 Exopharm Recent Developments
9.7 OmniSpiant
9.7.1 OmniSpiant Company Information, Head Office, Market Area and Industry Position
9.7.2 OmniSpiant Company Profile and Main Business
9.7.3 OmniSpiant Stem Cell Exosome Therapeutic Models, Specifications and Application
9.7.4 OmniSpiant Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.7.5 OmniSpiant Recent Developments
9.8 BrainStorm Cell Therapeutics
9.8.1 BrainStorm Cell Therapeutics Company Information, Head Office, Market Area and Industry Position
9.8.2 BrainStorm Cell Therapeutics Company Profile and Main Business
9.8.3 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.8.4 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.8.5 BrainStorm Cell Therapeutics Recent Developments
9.9 Novadip Biosciences
9.9.1 Novadip Biosciences Company Information, Head Office, Market Area and Industry Position
9.9.2 Novadip Biosciences Company Profile and Main Business
9.9.3 Novadip Biosciences Stem Cell Exosome Therapeutic Models, Specifications and Application
9.9.4 Novadip Biosciences Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.9.5 Novadip Biosciences Recent Developments
9.10 Unicyte AG
9.10.1 Unicyte AG Company Information, Head Office, Market Area and Industry Position
9.10.2 Unicyte AG Company Profile and Main Business
9.10.3 Unicyte AG Stem Cell Exosome Therapeutic Models, Specifications and Application
9.10.4 Unicyte AG Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.10.5 Unicyte AG Recent Developments
9.11 Exogenus Therapeutics
9.11.1 Exogenus Therapeutics Company Information, Head Office, Market Area and Industry Position
9.11.2 Exogenus Therapeutics Company Profile and Main Business
9.11.3 Exogenus Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.11.4 Exogenus Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.11.5 Exogenus Therapeutics Recent Developments
9.12 Creative Medical Tech
9.12.1 Creative Medical Tech Company Information, Head Office, Market Area and Industry Position
9.12.2 Creative Medical Tech Company Profile and Main Business
9.12.3 Creative Medical Tech Stem Cell Exosome Therapeutic Models, Specifications and Application
9.12.4 Creative Medical Tech Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.12.5 Creative Medical Tech Recent Developments
9.13 Anjarium Biosciences
9.13.1 Anjarium Biosciences Company Information, Head Office, Market Area and Industry Position
9.13.2 Anjarium Biosciences Company Profile and Main Business
9.13.3 Anjarium Biosciences Stem Cell Exosome Therapeutic Models, Specifications and Application
9.13.4 Anjarium Biosciences Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.13.5 Anjarium Biosciences Recent Developments
9.14 Capricor Therapeutics
9.14.1 Capricor Therapeutics Company Information, Head Office, Market Area and Industry Position
9.14.2 Capricor Therapeutics Company Profile and Main Business
9.14.3 Capricor Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.14.4 Capricor Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.14.5 Capricor Therapeutics Recent Developments
9.15 Kimera Labs ReNeuron
9.15.1 Kimera Labs ReNeuron Company Information, Head Office, Market Area and Industry Position
9.15.2 Kimera Labs ReNeuron Company Profile and Main Business
9.15.3 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Models, Specifications and Application
9.15.4 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.15.5 Kimera Labs ReNeuron Recent Developments
9.16 Stem Cell Medicine
9.16.1 Stem Cell Medicine Company Information, Head Office, Market Area and Industry Position
9.16.2 Stem Cell Medicine Company Profile and Main Business
9.16.3 Stem Cell Medicine Stem Cell Exosome Therapeutic Models, Specifications and Application
9.16.4 Stem Cell Medicine Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.16.5 Stem Cell Medicine Recent Developments
9.17 Codiak Biosciencesare
9.17.1 Codiak Biosciencesare Company Information, Head Office, Market Area and Industry Position
9.17.2 Codiak Biosciencesare Company Profile and Main Business
9.17.3 Codiak Biosciencesare Stem Cell Exosome Therapeutic Models, Specifications and Application
9.17.4 Codiak Biosciencesare Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.17.5 Codiak Biosciencesare Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com